Acute erythroid leukemia.
Zuo Z, Polski JM, Kasyan A, Medeiros LJ.
Arch Pathol Lab Med. 2010 Sep;134(9):1261-70. doi: 10.5858/2009-0350-RA.1.
A History and Current Understanding of Acute Erythroid Leukemia.
Alexander C.
Clin Lymphoma Myeloma Leuk. 2023 Aug;23(8):583-588. doi: 10.1016/j.clml.2023.04.011. Epub 2023 Apr 28.
Chemotherapeutics for Acute Erythroid Leukemia: Research, Present and Future.
Liao Z, Li J, Wu J, Liu J, Sun S.
Curr Mol Med. 2021;21(10):819-831. doi: 10.2174/1566524021666210121142316.
Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes.
Fernandes P, Waldron N, Chatzilygeroudi T, Naji NS, Karantanos T.
Int J Mol Sci. 2024 Jun 6;25(11):6256. doi: 10.3390/ijms25116256.
Modeling acute erythroid leukemia via CRISPR.
Zhang JP, Cheng T.
Blood. 2021 Mar 25;137(12):1565-1567. doi: 10.1182/blood.2020010544.
Pure erythroid leukemia.
Wang W, Wang SA, Medeiros LJ, Khoury JD.
Am J Hematol. 2017 Mar;92(3):292-296. doi: 10.1002/ajh.24626. Epub 2017 Feb 3.
Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group.
Chisholm KM, Heerema-McKenney AE, Choi JK, Smith J, Ries RE, Hirsch BA, Raimondi SC, Alonzo TA, Wang YC, Aplenc R, Sung L, Gamis AS, Meshinchi S, Kahwash SB.
Blood Adv. 2020 Dec 8;4(23):6000-6008. doi: 10.1182/bloodadvances.2020002712.
[Molecular pathogenesis and therapeutic targets in acute erythroid leukemia].
Takeda J.
Rinsho Ketsueki. 2022;63(2):121-133. doi: 10.11406/rinketsu.63.121.
Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases.
Reichard KK, Tefferi A, Abdelmagid M, Orazi A, Alexandres C, Haack J, Greipp PT.
Blood Cancer J. 2022 Nov 2;12(11):147. doi: 10.1038/s41408-022-00746-x.
Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification.
Chen Y, Pourabdollah M, Atenafu EG, Tierens A, Schimmer A, Chang H.
Leuk Res. 2017 Oct;61:39-43. doi: 10.1016/j.leukres.2017.08.011. Epub 2017 Aug 25.
